-
www.ahrq.gov/patient-safety/settings/hospital/match/chapter-6.html
July 01, 2022 - Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation
Chapter 6. Assessment and Process Evaluation
Previous Page Next Page
Table of Contents
Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation
Introduction
Chapte…
-
www.ahrq.gov/sites/default/files/wysiwyg/action-alliance/action-alliance-webinar-june-2024.pdf
January 01, 2024 - National Action Alliance Webinar June 18, 2024: Empowering Patient Voice in Safety Strategies
Empowering Patient Voice in Safety Strategies:
Understanding and Operationalizing the National Action
Alliance Aim #2
NATIONAL WEBINAR SERIES
June 18, 2024
Housekeeping Instructions
• This webinar will be recorded a…
-
psnet.ahrq.gov/node/33568/psn-pdf
June 15, 2024 - Root Cause Analysis
June 15, 2024
Root Cause Analysis. PSNet [internet]. 2019.
https://psnet.ahrq.gov/primer/root-cause-analysis
PSNet primers are regularly reviewed and updated by the UC Davis PSNet Editorial Team to ensure that
they reflect current research and practice in the patient safety field. Last reviewed…
-
www.ahrq.gov/sites/default/files/wysiwyg/news/events/ahrq-research-summit/adelman-summit2016.pdf
January 01, 2016 - Diagnostic Error Measures: For Quality Improvement & Patient Safety Research
Diagnostic Error Measures:
For Quality Improvement &
Patient Safety Research
Jason Adelman, MD, MS
Chief Patient Safety Officer & Associate Chief Quality Officer
Columbia University Medical Center
NewYork-Presbyterian Hospital
Process
…
-
effectivehealthcare.ahrq.gov/sites/default/files/manges.pdf
May 29, 2025 - ENVIRONMENTAL PROTECTION AGENCY
INNOVATIONS CONFERENCE -- ENVIRONMENTAL PROTECTION AGENCY
SPEAKER: ELLEN MANGES,
SENIOR ADVISOR, OFFICE OF SOLID WASTE AND EMERGENCY RESPONSE (OSWER)
ENVIRONMENTAL PROTECTION AGENCY (EPA)
MANGES: My name is Ellen Manges. I'm a senior advisor. I…
-
www.ahrq.gov/ncepcr/reports/grants-transform/overview.html
March 01, 2017 - Findings From the AHRQ Transforming Primary Care Grant Initiative: A Synthesis Report
Overview of the 14 Transforming Primary Care Grants
Previous Page Next Page
Table of Contents
Findings From the AHRQ Transforming Primary Care Grant Initiative: A Synthesis Report
Executive Summary
Introduction…
-
pso.ahrq.gov/sites/default/files/wysiwyg/PSO-listing-guide-2022.pdf
January 01, 2022 - component
organization once listed as a PSO; and 2) the component PSO will notify AHRQ within 5 calendar
days … meets this
requirement by submitting the Two Bona Fide Contracts Requirement Form no later than 45 days … provider arises that requires disclo-
sure
The PSO must submit a Disclosure Statement to AHRQ within 45 days … Continued Listing Form
Each PSO must submit the Certification for Continued Listing Form no later than 75 days … organization once listed
as a PSO and that the component
PSO will notify the Secretary within
5 calendar days
-
digital.ahrq.gov/sites/default/files/docs/page/EightSuccessStories_092810.pdf
September 01, 2010 - receiving training on use of the software, partner clinicians shadowed
specialists at the UNM for 1 to 2 days … available only intermittently,
or a retail pharmacist would work for the hospital only a couple of days … The planning process, which was facilitated by SMRTNET staff, was completed in 4 days, with 50
hospital
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
July 01, 2013 - from a hospital; it aids in their recuperation and rehabilitation and
typically lasts less than 30 days … Comments to summary (if any) due from stakeholders within 5 working
days
c. … Stakeholders prioritization responses due within 5 working days
C-1
Title Page: Long-Term Care
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
July 11, 2022 - However, manifestations
of preeclampsia may take days or weeks to resolve, with some cases
presenting
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Rudman.pdf
January 01, 2004 - percent, and the Missouri study, where the ME occurrence rate
increased from 1.3 to 1.5 per 100 patient days
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - 1
Comparative Effectiveness Review
Number 168
Diagnosis and Management of Infantile
Hemangioma
Executive Summary
Introduction
Infantile hemangiomas (IH) are the most
common tumors of childhood. IH are
benign but possess potential for local
tissue damage, ulceration, infection,
bleeding, functional impact, and…
-
www.ahrq.gov/sites/default/files/2024-01/france-report.pdf
January 01, 2024 - (N = 60)
p Value
Infant weight at surgery (kg), median (IQR) 3.2 (1.3) 2.8 (1.1) p < 0.001
Age (days
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
March 01, 2018 - Within 10 days of the pilot starting the ‘go live’ phase, Alliance began generating weekly reports as … Live Pilot
End-to-end implementation testing of the Statin Use artifact occurred over the course of 13 days
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Population – neonates (28 days after birth) (specify age range): No.
p. … Population – infants (29 days to 1 year) (specify age range): No.
q.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
February 01, 2008 - Median length of hospital
stay (1.2 vs. 2.7 days) and median length of
catheterization (7 vs. 13 days … • Death within 30 days of RP is approximately 0.5% in Medicare
recipients age 65 and over.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fFns4N2J-t5EGC5BUdRuu
October 23, 2023 - tenofovir are reached in peripheral blood mono-
nuclear cells and rectal tissue after approximately 7 days … of daily oral
dosing and in cervicovaginal tissues at approximately 20 days.11
Patients can continue … aged 18 to
45 years (median, 25 years), reported engaging in vaginal inter-
course in the prior 30 days
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
August 22, 2023 - tenofovir are reached in peripheral blood mononuclear cells and rectal tissue after approximately 7 days … of daily oral dosing and in cervicovaginal tissues at approximately 20 days. 11
Patients can continue … were aged 18 to 45 years (median, 25 years), reported engaging in vaginal intercourse in the prior 30 days
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary13/child-maltreatment-primary-care-interventions-2013
January 15, 2013 - groups include diffusion of the SEEK model to the control group clinics when physicians changed clinic days … episodes of hospitalizations for all indications (19 vs. 36; P < 0.01) and fewer mean hospitalization days … and home visits
Usual care
Prenatal, 2; postnatal, 10
ED visits Hospitalizations (number and days
-
www.ahrq.gov/sites/default/files/2024-01/jones2-report.pdf
January 01, 2024 - . (%) Total 1/16 (6%) 0/5 (0%) 1/6 (17%) 0/5 (0%) 1.0‡
patient days, mean (SD) 2,972 (1893) 3,100 (1556 … coordination score out of 84, mean (SD)* 54.3 (8.5) 44.8 (3.4) 54.0 (2.6) 64.0 (4.3) NA
Total patient days … post-fall
huddle reports
submitted by hospitals
• Count of injurious and total falls
• Count of patient days